Joni Vastola
Nurse Practitioner · Mt Juliet, TNNPI 1518363340
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Phathom Pharmaceuticals, Inc. accounts for 64.6% of it on its own, with 38 other manufacturers making up the rest. 2025 is the largest year on record at $36,771, more than ten times the $986 reported in 2021. Among nurse practitioner clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 742 payments — averaging $79.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Phathom Pharmaceuticals, Inc.$38K
- AbbVie$14K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Johnson & Johnson$894
- Takeda Pharmaceuticals U.S.A., Inc.$779
- Regeneron Healthcare Solutions, Inc.$668
- plus $4K from 33 others
What the payments were for
- Consulting fees$2500%
- Speaking & faculty fees$30,52052%
- Travel & lodging$16,90729%
- Food & beverage$11,24419%
- Education$2750%
- Other$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$59,230 in reported general payments places this provider in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SucraidSacrosidase | 19 | $264,762 |
| ZenpepLipase/Protease/Amylase | 22 | $144,205 |
| XifaxanRifaximin | 19 | $52,826 |
| LinzessLinaclotide | 19 | $19,627 |
| VoqueznaVonoprazan Fumarate | 14 | $14,088 |
| MovantikNaloxegol Oxalate | 18 | $9,337 |
| Mesalamine | 12 | $5,057 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 19 | $3,026 |
| Mesalamine ErMesalamine | 13 | $2,770 |
| Esomeprazole Magnesium | 22 | $1,794 |
| SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag | 15 | $1,747 |
| Pantoprazole Sodium | 171 | $1,728 |
| Colestipol Hcl | 18 | $974 |
| CholestyramineCholestyramine (With Sugar) | 21 | $897 |
| Lactulose | 15 | $611 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| QOL Medical, LLCSucraid | $271 | $264,76219 claims |
| Aimmune Therapeutics, Inc.Zenpep | $262 | $144,20522 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $1,269 | $52,82619 claims |
| AbbVieLinzess | $13,642 | $19,62719 claims |
| Phathom Pharmaceuticals, Inc.Voquezna | $38,268 | $14,08814 claims |
| Redhill Biopharma Inc.Movantik | $24 | $9,33718 claims |
| Braintree Laboratories, Inc.Sutab, Suflave | $455 | $4,77334 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.
Other nurse practitioner in Mt Juliet
- Amy HatcherMurfreesboro$1.1M
- Karen RodenKnoxville$265K
- Susan UtleyNashville$194K
- Whitney EricksonMemphis$159K
- Erica HembreeKnoxville$125K
- Brooke FaughtNashville$87K
- Lauren WelchNashville$71K
- Cara StoutKingsport$71K
- S Marie HamiltonOoltewah$64K
- Cynthia WilsonChattanooga$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.